COVID-19 outbreak: Challenges in pharmacotherapy based on pharmacokinetic and pharmacodynamic aspects of drug therapy in patients with moderate to severe infection

The new coronavirus (COVID-19) was first detected in Wuhan city of China in December 2019. Most patients infected with COVID-19 had clinical presentations of dry cough, fever, dyspnea, chest pain, fatigue and malaise, pneumonia, and bilateral infiltration in chest CT. Soon COVID-19 was spread around...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghasemiyeh, Parisa, Mohammadi-Samani, Soliman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500907/
https://www.ncbi.nlm.nih.gov/pubmed/32980626
http://dx.doi.org/10.1016/j.hrtlng.2020.08.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500907/
https://www.ncbi.nlm.nih.gov/pubmed/32980626
http://dx.doi.org/10.1016/j.hrtlng.2020.08.025

Ejemplares similares